Immune landscape of pancreatic neuroendocrine tumours (PanNETs)

被引：0
|
作者：
Young, K. [1 ]
Ragulan, C. [2 ]
Nyamundanda, G. [2 ]
Patil, Y. [2 ]
Lawlor, R. T. [3 ]
Cunningham, D. [1 ]
Starling, N. [1 ]
Scarpa, A. [3 ]
Sadanandam, A. [2 ]
机构：
[1] Royal Marsden NHS Fdn Trust, GI & Lymphoma Res Dept, Sutton, Surrey, England
[2] Inst Canc Res, Mol Pathol, Sutton, Surrey, England
[3] Univ & Hosp Trust Verona, ARC Net Ctr Appl Res Canc, Verona, Italy
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
428O
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Whole-genome landscape of pancreatic neuroendocrine tumours (vol 543, pg 65, 2017)
    Scarpa, Aldo
    Hang, David K. C.
    Nones, Katia
    Corbo, Vincenzo
    Patch, Ann-Marie
    Bailey, Peter
    Lawlor, Rita T.
    Johns, Amber L.
    Miller, David K.
    Mafficini, Andrea
    Rusev, Borislav
    Scardoni, Maria
    Antonello, Davide
    Barbi, Stefano
    Sikora, Katarzyna O.
    Cingarlini, Sara
    Vicentini, Caterina
    McKay, Skye
    Quinn, Michael C. J.
    Bruxner, Timothy J. C.
    Christ, Angelika N.
    Harliwong, Ivon
    Idrisoglu, Senel
    McLean, Suzanne
    Nourse, Craig
    Nourbakhsh, Ehsan
    Wilson, Peter J.
    Anderson, Matthew J.
    Fink, J. Lynn
    Newell, Felicity
    Waddell, Nick
    Holmes, Oliver
    Kazakoff, Stephen H.
    Leonard, Conrad
    Wood, Scott
    Xu, Qinying
    Nagaraj, Shivashankar Hiriyur
    Amato, Eliana
    Dalai, Irene
    Bersani, Samantha
    Cataldo, Ivana
    Tos, Angelo P. Dei
    Capelli, Paola
    Davi, Maria Vittoria
    Landoni, Luca
    Malpaga, Anna
    Miotto, Marco
    Whitehall, Vicki L. J.
    Leggett, Barbara A.
    Harris, Janelle L.
    NATURE, 2017, 550 (7677) : 548 - 548
  • [32] Outcomes After Cessation of Therapy With Alkylating Agents (AA) for Pancreatic Neuroendocrine Tumors (PanNETS)
    Wu, Y. Linda
    Reidy, Diane
    Bielska, Agata
    Kelly, Virginia
    Raj, Nitya
    PANCREAS, 2020, 49 (03) : 490 - 490
  • [33] Role of Tumor-Associated Macrophages in the Clinical Course of Pancreatic Neuroendocrine Tumors (PanNETs)
    Cai, Lei
    Michelakos, Theodoros
    Deshpande, Vikram
    Arora, Kshitij S.
    Yamada, Teppei
    Ting, David T.
    Taylor, Marty S.
    Fernandez-del Castillo, Carlos
    Warshaw, Andrew L.
    Lillemoe, Keith D.
    Ferrone, Soldano
    Ferrone, Cristina R.
    CLINICAL CANCER RESEARCH, 2019, 25 (08) : 2644 - 2655
  • [34] Outcomes after cessation of therapy with alkylating agents (AA) for pancreatic neuroendocrine tumors (panNETs).
    Wu, Linda
    Reidy, Diane Lauren
    Bielska, Agata
    Kelly, Virginia
    Raj, Nitya Prabhakar
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [35] Preoperative assessment of microvessel density in nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs)
    Battistella, Anna
    Partelli, Stefano
    Andreasi, Valentina
    Marinoni, Ilaria
    Palumbo, Diego
    Tacelli, Matteo
    Lena, Marco Schiavo
    Muffatti, Francesca
    Mushtaq, Junaid
    Capurso, Gabriele
    Arcidiacono, Paolo Giorgio
    De Cobelli, Francesco
    Doglioni, Claudio
    Perren, Aurel
    Falconi, Massimo
    SURGERY, 2022, 172 (04) : 1236 - 1244
  • [36] Sunitinib use is justified for pancreatic neuroendocrine tumours
    Siddall, Rhonda
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2010, 71 (11) : 610 - 610
  • [37] Pazopanib: a new drug for pancreatic neuroendocrine tumours
    Kwekkeboom, Dik J.
    LANCET ONCOLOGY, 2015, 16 (06): : 606 - 607
  • [38] Pancreatic neuroendocrine tumours: spectrum of imaging findings
    Bicci, Eleonora
    Cozzi, Diletta
    Ferrari, Riccardo
    Grazzini, Giulia
    Pradella, Silvia
    Miele, Vittorio
    GLAND SURGERY, 2020, 9 (06) : 2215 - 2224
  • [39] Diagnostics and treatment in functional pancreatic neuroendocrine tumours
    Muessig, K.
    Dudziak, K.
    Horger, M.
    Anlauf, M.
    Goretzki, P. E.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2011, 136 (24) : 1319 - 1330
  • [40] Pancreatic neuroendocrine tumours – new therapeutic concepts
    M. Troch
    B. Kiesewetter
    Markus Raderer
    memo - Magazine of European Medical Oncology, 2012, 5 (1) : 63 - 65
12345